rs2280869
Variant names:
Variant summary
Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1
The NM_001205293.3(CACNA1E):c.*216T>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0827 in 448,958 control chromosomes in the GnomAD database, including 2,492 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.080 ( 711 hom., cov: 33)
Exomes 𝑓: 0.084 ( 1781 hom. )
Consequence
CACNA1E
NM_001205293.3 3_prime_UTR
NM_001205293.3 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.345
Publications
8 publications found
Genes affected
CACNA1E (HGNC:1392): (calcium voltage-gated channel subunit alpha1 E) Voltage-dependent calcium channels are multisubunit complexes consisting of alpha-1, alpha-2, beta, and delta subunits in a 1:1:1:1 ratio. These channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. This gene encodes the alpha-1E subunit of the R-type calcium channels, which belong to the 'high-voltage activated' group that maybe involved in the modulation of firing patterns of neurons important for information processing. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Apr 2011]
CACNA1E Gene-Disease associations (from GenCC):
- developmental and epileptic encephalopathy, 69Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Illumina
- genetic developmental and epileptic encephalopathyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- neurodevelopmental disorderInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -18 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.41).
BP6
Variant 1-181799050-T-C is Benign according to our data. Variant chr1-181799050-T-C is described in ClinVar as Benign. ClinVar VariationId is 1228100.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.276 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CACNA1E | ENST00000367573.7 | c.*216T>C | 3_prime_UTR_variant | Exon 48 of 48 | 1 | NM_001205293.3 | ENSP00000356545.2 | |||
| CACNA1E | ENST00000367570.6 | c.*216T>C | 3_prime_UTR_variant | Exon 47 of 47 | 1 | ENSP00000356542.1 | ||||
| CACNA1E | ENST00000621791.4 | c.*216T>C | 3_prime_UTR_variant | Exon 46 of 46 | 1 | ENSP00000481619.1 | ||||
| CACNA1E | ENST00000360108.7 | c.*216T>C | downstream_gene_variant | 5 | ENSP00000353222.3 |
Frequencies
GnomAD3 genomes AF: 0.0802 AC: 12203AN: 152164Hom.: 706 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
12203
AN:
152164
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0840 AC: 24932AN: 296676Hom.: 1781 Cov.: 4 AF XY: 0.0844 AC XY: 12737AN XY: 150888 show subpopulations
GnomAD4 exome
AF:
AC:
24932
AN:
296676
Hom.:
Cov.:
4
AF XY:
AC XY:
12737
AN XY:
150888
show subpopulations
African (AFR)
AF:
AC:
664
AN:
8838
American (AMR)
AF:
AC:
1659
AN:
10410
Ashkenazi Jewish (ASJ)
AF:
AC:
672
AN:
10196
East Asian (EAS)
AF:
AC:
7321
AN:
24086
South Asian (SAS)
AF:
AC:
1324
AN:
11476
European-Finnish (FIN)
AF:
AC:
1269
AN:
22464
Middle Eastern (MID)
AF:
AC:
61
AN:
1472
European-Non Finnish (NFE)
AF:
AC:
10481
AN:
189076
Other (OTH)
AF:
AC:
1481
AN:
18658
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
1012
2024
3035
4047
5059
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
138
276
414
552
690
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0801 AC: 12203AN: 152282Hom.: 711 Cov.: 33 AF XY: 0.0851 AC XY: 6339AN XY: 74454 show subpopulations
GnomAD4 genome
AF:
AC:
12203
AN:
152282
Hom.:
Cov.:
33
AF XY:
AC XY:
6339
AN XY:
74454
show subpopulations
African (AFR)
AF:
AC:
3111
AN:
41568
American (AMR)
AF:
AC:
2191
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
AC:
205
AN:
3472
East Asian (EAS)
AF:
AC:
1483
AN:
5146
South Asian (SAS)
AF:
AC:
552
AN:
4824
European-Finnish (FIN)
AF:
AC:
693
AN:
10620
Middle Eastern (MID)
AF:
AC:
13
AN:
294
European-Non Finnish (NFE)
AF:
AC:
3659
AN:
68032
Other (OTH)
AF:
AC:
149
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
578
1157
1735
2314
2892
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
136
272
408
544
680
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
624
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Mar 15, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.